@grandslam... FWIW, they told me last week that they are wrapping up Q3 reporting and will be moving on to filing the Form 10 with the SEC shortly, as promised. I have no reason to doubt them -- this is what they've been saying publicly all year. My only criticism with this issue is, as we all know, they put out some garbage at the end of 2020 to the effect of refiling in January 2021. I suspect that was done in haste, before or during the reshuffling of personnel, without a master plan in place. My guess is things settled down and they came up with a more rational plan for recovery that considered the full business situation. Basically, it made no sense to refile with the SEC while their business was dormant. It made more sense to wait until they could re-establish a tailwind. And I think we're seeing that now with the FDA study, key hires and consulting relationships, the European Wellness deal they just announced, and the recovery of certain core businesses now well underway -- with more news to come soon, I suspect. All that said, I'm not going to be entirely comfortable with this situation until I see a value associated with my shares in my brokerage account, without any reverse splits or other shenanigans. They promised that no such things were being contemplated, and publicly stated that the new public equity structure would include legacy shareholders. I have no reason to doubt them. But I want to see it. I accumulated a significant position in this company over the years, and I expect it to be intact when this episode is over. But I completely agree that it needs to happen soon, and I think they understand that. Otherwise, why pay the auditors?
News 
Market Data 
Discover 
AI
